This talk will provide a comprehensive overview of the limitations of ‘traditional’ clinical tests that may be overcome by augmenting these with objective biometrics. We will provide an overview of the development of biometrics and statistical models as applied to neurodevelopmental disorders. This will include an overview of the implementation of such models to facilitate the early detection of disorders in the neonate and the tracking of neurodevelopment. Further clinical examples will be provided including an application to track, and objectively profile, the impact of therapeutic intervention for individuals with SPD. This session will provide attendees with an accessible, yet detailed, overview of novel biometrics, and a working conceptualization of implementation as demonstrated via clinical examples.
Level: Intermediate
Length: 1 1/2 hours
Timeframe for access: Once you first choose to "Launch" this course, you will have 45 days to access the content as often as you like. Your 45-day window for access will not begin until you first click the "Launch" button.
Part 1: Dynamic diagnosis and objective outcome measures of individuals and dyads.
Learning Objectives:
- Explain the design of tasks to evaluate the nervous system performance
- Outline the
requirements for an objective standardized test that is sensitive to the underlying dynamics of physical change related to factors such as age, or therapeutic interventions
Part 2: Application: Therapy evaluation
Learning Objectives:
- Describe the limitations of current clinical tests and the ability to integrate new mathematical concepts
- Explain the design and implementation of objective biometrics for use within clinical settings
Presenter:
Dr. Elizabeth Torres is a Professor at Rutgers University and a scientific innovator who has brought emerging computer science technology to autism. She attained the first NSF theoretical / computational grant to Autism (in 2009) and since then has raised over 8 million research-dollars in autism-related research with a focus on developing smart technology to create support and accommodations for autistic individuals. This work has led to 4 granted US / international patents with technology informed and guided by the autistic nervous systems development across the lifespan. Torres has authored two peer-reviewed printed books, three peer-reviewed electronic-books related to autistic somato-motor-sensing differences and over 50 peer-reviewed publications with well over half a million online hits on her translational research. She has developed new scientific methods to evoke bodily autonomy and agency in Autism and created a new vision for the only New Jersey Autism Center of Excellence that is funded by the NJ Governor’s Council for the Medical Research and Treatments of Autism and the NJ DOH. This new vision brings together a highly interdisciplinary coalition of researchers from top institutions across the state, to build digital methods to improve Autism treatments, as informed by the autistic community. The aim of her work is to help guarantee insurance coverage to diversify treatments, and to select the most adequate combinations of treatments based on objective outcome measures of their effectiveness, beyond subjective observation and opinion alone. She is an active speaker engaging many audiences from industry, biopharma, and schools, bringing awareness across the world of the need for a strengths-based model leading to embrace the social agency of autistic individuals and their families.
Continuing Education:
STAR Institute is an AOTA Approved Provider of continuing education. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA.
1.5 Professional Contact Hours (.15 AOTA CEUs) are awarded for full completion of this program.
Course Completion Requirements:
Upon full completion of the course video, participants must complete and pass a quiz with at least 80% accuracy to receive a certificate of completion.